Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 22.10.2026 FEUZ IE00B8X9NY41 1,607,584.00 EUR 101,033,591.37   62.848  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 22.10.2026 H2O LN IE000Q8F0M81  700,002.00 USD  14,265,691.72   20.380  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 22.10.2026 FEM IE00B8X9NX34  300,002.00 USD  14,920,939.18   49.736  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 22.10.2026 FJAN.LN IE000MDKBOB3  150,002.00 USD   4,449,944.96   29.666  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 22.10.2026 FEXD.LN IE00BWTNMB87  440,903.00 USD  44,617,415.09  101.196  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 22.10.2026 FEX.LN IE00B8X9NW27 1,372,712.00 USD 157,156,732.00  114.486  ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical On...

DOVER, Del.--(BUSINESS WIRE)--Precisio Biotix Therapeutics, Inc. (“Precisio”), today announced new funding from Gates Foundation to advance a potential new treatment for bacterial vaginosis (BV), one of the most common vaginal conditions affecting women worldwide.BV occurs when beneficial bacteria that help maintain vaginal health are displaced by harmful bacteria. These harmful bacteria, particularly Gardnerella, can form protective biofilms that make them difficult to eliminate with antibiotic...

OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs in the following table for the month ending October 31, 2026. The distributions will be paid on or about November 6, 2026 to unitholders of record on October 30, 2026, with an ex-dividend date of October 30, 2026. Harvest ETF Ticker* Distribution Harvest Healthcare Leaders Income ETF HHL $0.0600 per unit Harvest Healthcare Leaders Income ETF (US) HHL.U $0....

BOTHELL, Wash. & PRINCETON, N.J.--(BUSINESS WIRE)--Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2-......